Compare MINISO Group Holding Ltd (MNSO) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MINISO Group Holding Ltd vs TransMedics Group Inc — how do they compare? MINISO Group Holding Ltd trades at $11.78 (market cap $3.58B), while TransMedics Group Inc trades at $89.47 (market cap $3.02B). The key difference: MINISO Group Holding Ltd is the larger of the two by market cap, and MINISO Group Holding Ltd pays a 5.6% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| MNSO | TMDX | |
|---|---|---|
Market Cap | $3.58B | $3.02B |
Sector | Technology | Technology |
52-Week High | $26.63 | $150.42 |
52-Week Low | $11.30 | $61.99 |
Enterprise Value | $4.25B | $3.41B |
Dividend Yield | 5.6% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MNSO trades at $11.9, down 1.16% on the day, with a bearish technical signal from moving averages despite a neutral oscillator stance. The company reported strong Q1 2026 earnings that beat expectations, with revenue growth of 28.5% year-over-year, and announced a $2 billion share repurchase program in June 2026 to enhance shareholder value. Valuation ratios appear reasonable with a P/E of 12.02 and P/S of 1.09, while profitability metrics show a net income margin of 8.98% and ROE of 18.88%.
The outlook is mixed; analyst consensus is 75% buy with potential upside from operational execution and buybacks, but risks include margin pressure from rising expenses and competitive threats in the value retail sector. The stock's recent underperformance versus the market highlights investor caution amid earnings volatility, requiring close monitoring of future quarterly results for sustained growth confirmation.
TransMedics Group (TMDX) trades at $87.02, down 2.62% on the day, amid mixed earnings performance. The stock shows strong profitability with a 22.69% net margin and 36.28% ROE, but recent quarters saw misses on EPS expectations. Technicals are bullish with moving averages supporting upside, while oscillators signal caution. Recent news highlights an ongoing legal investigation into fiduciary duties by company directors.
The outlook is cautiously optimistic with a consensus price target of $99.57 implying 14% upside, supported by bullish analyst ratings. Key risks include earnings volatility, rising costs impacting margins, and potential legal overhangs from the fiduciary investigation. Revenue growth remains a positive catalyst, but investors should monitor execution against future guidance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About MINISO Group Holding Ltd
MINISO Group Holding Ltd is a global lifestyle product retailer known for its aesthetically pleasing, high-quality, and low-cost goods. The company operates a network of branded stores worldwide, offering a diverse range of merchandise, including household goods, cosmetics, toys, and digital accessories. MINISO's business model emphasizes rapid product iteration, efficient supply chain management, and a joint venture and franchise partner network to facilitate its global expansion.
Read more on MNSO →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
